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Background: Selenium is considered a protective agent against free radicals through the maintenance of better
enzyme activity. The few studies examining the relationship between selenium and depression have yielded
inconsistent results and none of these studies considered the role of cognitive function in this context.
Methods: A cross-sectional evaluation of 1737 rural Chinese age 65 and over from two provinces in China was
conducted. Depressive symptoms were assessed using the Geriatric Depression Scale (GDS). Cognitive function was
assessed using various cognitive instruments. Selenium measures were obtained from nail samples. Other
information collected included demographic characteristics and medical history. Analysis of covariance models
were used to identify factors associated with GDS score.
Results: Higher selenium levels were associated with lower GDS scores adjusting for demographic and medical
conditions (p = 0.0321). However, the association between selenium and depressive symptoms was no longer
significant when cognitive function score was adjusted in the model (p = 0.2143).
Conclusions: Higher selenium level was associated with lower depressive symptoms without adjusting for
cognition in this cohort. However, after cognition was adjusted in the model the association between selenium and
depressive symptoms was no longer significant, suggesting that selenium’s association with depressive symptoms
may be primarily through its association with cognitive function.Background
Selenium is a trace element associated with the antioxi-
dant enzyme glutathione peroxidase (GP-x) and is con-
sidered a protective agent against free radicals through
the maintenance of better enzyme activity. Several stud-
ies examining the relationship between selenium and de-
pression have provided inconsistent results, with some
showing lower selenium levels associated with greater
risk of depression [1-4] while others showing no associ-
ation [5]. It is interesting to observe that a beneficial ef-
fect of selenium supplementation was mostly seen when
a substantial number of participants had low dietary sel-
enium levels and selenium supplementation in subjects
with already adequate selenium levels does not seem to* Correspondence: sgao@iupui.edu
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reproduction in any medium, provided the orconfer benefit on mood or depressive symptoms [1-3]. It
is also worth noting that none of these studies consid-
ered cognitive function of the study participants.
Research has shown that the brain has a unique fea-
ture in selenium metabolism by storing selenium so that
GP-x activity in the brain does not decrease as fast as in
the liver after a low selenium diet [6,7]. Based on this
observation, it has been hypothesized that long-term ex-
posure to low selenium may be needed to impact brain
function such as mood or cognitive function [8]. Given
that selenium content in food, especially grain, is highly
variable depending on selenium content of the soils in
which they are grown [9], studying the relationship be-
tween long-term selenium exposure and brain functions
may be difficult in populations that are mobile and con-
sume foods produced in different areas of the world.
Moreover, supplements containing selenium are often
ingested particularly by health conscious individuals thus
confounding study results.. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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portunity for examining the relationship between long-
term selenium exposure and depressive symptoms. The
rural Chinese are stable with most living in the same vil-
lage throughout their entire life and consuming locally
grown food. In addition, it is rare for them to take diet-
ary supplements. Our group has previously reported on
the association between selenium and cognitive function
in this cohort. In this article, we investigate the associ-
ation between selenium levels and depressive symptoms
and examine the role of cognitive function on the associ-




A total of 2000 older adults were recruited for the Selen-
ium and Cognitive Decline study, a longitudinal epide-
miologic project funded by the National Institute of
Health examining the long-term impact of selenium on
cognitive function in rural elderly Chinese [8]. Two
counties from Sichuan Province in southwestern China
and two counties from Shandong Province in eastern
China were selected based on: rural areas with historic-
ally low in- and out-migration, wide range of selenium
levels but comparable trace elements otherwise, compar-
able age and gender proportions, and sufficient popula-
tion to provide 500 elderly subjects per county. Sites
with known endemic diseases (including Keshan disease,
Kaschin-Beck disease, goiter and Cretinism, and fluor-
osis) were excluded from consideration.
For each village included in the study, a team of inter-
viewers who were employees from provincial or county
offices of Chinese Center for Disease Control traveled to
the area, established a temporary headquarter and con-
ducted a complete census of residents over age 65 in the
area. They enrolled eligible residents by going door-to-
door, obtaining informed consent before conducting the
interview and collecting biological samples. There were
no refusals. However, a few subjects with hearing pro-
blems were not enrolled. The study was approved by In-
diana University Institutional Review Board and the
Institute for Environmental Health and Related Safety,
Chinese Center for Disease Control and Prevention.
A second evaluation of this cohort was conducted ap-
proximately two and half years after the initial evalu-
ation. In addition to cognitive assessment, the Geriatric
Depression Scale (GDS) was administered to all partici-
pants during the second evaluation.
Measure of depressive symptoms
The GDS is a 30-item scale developed specifically for
use in elderly populations [10]. GDS scores between 11
and 20 are generally considered to represent significantmild depression and scores of 21 or higher are consid-
ered severe depression [11]. The GDS was validated with
a psychiatric outpatient sample in a previous study in
Chinese age 60 or older [12]. Internal consistency was
high (alpha = 0.89), and the test-retest reliability was
0.85. The GDS also showed excellent criterion-related
validity (0.95) when compared to psychiatrist diagnosis,
and substantial concurrent validity (0.96) when com-
pared with the Center for Epidemiologic Studies Depres-
sion Scale (CES-D) [13]. Although the GDS is generally
self administered, because of low literacy rates in our co-
hort, the GDS was administered by trained interviewers
in face-to-face interviews.Selenium measures
Nail samples from all study subjects were collected dur-
ing the initial interview and stored in clean plastic bags
labeled with participant identification numbers. The
method of fluorometric determination of trace amount
of selenium with 2,3-diaminonaphthalene, described in
details elsewhere [14], was used to determine trace
amounts of selenium in nail samples. Quality control in
the laboratory was maintained by using certified refer-
ence materials and by inter-laboratory comparisons.
Quality control measures used for the laboratory ana-
lyses were described in details previously [8].Cognitive assessment
Cognitive assessment was conducted in face-to-face
interviews using the Community Screening Instrument
for Dementia (CSID), Consortium to Establish a Registry
for Alzheimer’s Disease (CERAD) 10-word list learning
and recall,[15] Indiana University (IU) Story Recall, Ani-
mal Fluency test [16], and IU Token test at baseline and
at the 2.5 year follow-up. The CSID was developed as a
screening tool for dementia in populations with various
cultural backgrounds and literacy levels. The CSID has
demonstrated good two week test retest reliability and
inter-rater reliability as well as good validity in detecting
dementia in various populations [17,18]. CSID scores
range from 0 to 30. The CERAD Word List Learning
test is one of the measures from the CERAD neuro-
psychological assessment battery which was designed to
assess cognitive skills in the elderly. The IU Story Recall
task was created by the research team to be suitable to
the Chinese culture and the rural population. The Ani-
mal Fluency test is a measure of executive function in
which a subject names as many animals as possible in 60
seconds. The IU Token Test is a brief measure of lan-
guage comprehension and working memory [19]. The
validity of the CSID, CERAD word list learning and re-
call, and the Animal Fluency test have been previously
established in Chinese population and elsewhere [20].
Table 1 Mean GDS scores by participants’ characteristics
N Mean SD p-value
Age group
65-74 1002 7.68 5.83 <0.0001
75-84 652 9.02 5.86
85+ 83 9.38 5.55
Gender
Male 815 7.52 5.77 <0.0001
Female 922 8.92 5.87
Ever attended school
Yes 676 7.05 5.73 <0.0001
No 1061 9.04 5.82
Marital status
Married 1016 7.65 5.71 <0.0001*
Widowed 704 9.08 5.91
Other 17 11.47 8.18
Living arrangement#
With spouse 828 7.39 5.69 <0.0001
With children 585 8.85 5.58
Living alone 311 9.60 6.51
Body Mass Index tertiles
< 20.45 578 8.80 5.94 0.0025
[20.45, 23.24) 577 8.38 6.02
≥ 23.24 582 7.62 5.57
Ever drink alcohol
Yes 697 7.59 5.73 <0.0001
No 1040 8.72 5.91
Smoking
Current smoker 553 7.72 5.89 0.0013
Former smoker 148 7.39 5.57
Non-smoker 1036 8.68 5.85
History of Cancer
Yes 33 8.85 6.51 0.5634
No 1704 8.25 5.85
History of Parkinson’s
Yes 36 8.67 6.04 0.6774
No 1701 8.26 5.86
History of diabetes
Yes 75 8.25 5.83 0.5435
No 1662 8.67 6.64
History of hypertension^
Yes 1029 8.36 5.83 0.4141
No 708 8.13 5.91
History of stroke#
Yes 45 10.20 6.97 0.0245
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Other information collected during the second evaluation
included age, gender, whether the participant attended
school and years of schooling, marital status, household
composition, alcohol consumption and smoking history,
history of cancer, Parkinson’s disease, diabetes, hyperten-
sion, stroke, heart attack, head injury and bone fracture
by self-report. Participants’ height and weight were also
measured during the interview. BMI was derived from
height and weight measurements. Blood spots on filter
paper were collected from all study participants during
the baseline evaluation. APOE genotype was determined
by eluting DNA from a dried blood spot [21] followed by
HhaI digestion of amplified products [22].
Statistical analysis
We conduct cross-sectional analysis using GDS scores
and cognitive scores collected at the second evaluation
of this cohort. Mean GDS scores were compared by par-
ticipants’ characteristics using analysis of variance
(ANOVA) or t-tests. Significant factors in univariate as-
sociation with GDS scores were included in Analyses of
Covariance (ANCOVA) models. Two sets of ANCOVA
models were used to examine selenium’s relationship
with GDS scores. The first model included all significant
covariates in addition to selenium levels as independent
variables. The second ANCOVA model included a com-
posite cognitive z-score obtained from the time of the
GDS administration as well as all variables in the first
model. To ensure robust estimation results, we also con-
ducted nonparametric ANCOVA by using normal scores
derived from the ranks of the GDS scores [23]. The
composite cognitive z-score was created by using the
average of standardized scores of the six cognitive tests
[24,25]. To detect potential non-linear relationship be-
tween BMI, selenium levels and GDS scores, we also
conducted models using tertile groups. Logistic regres-
sion models were used to investigate whether selenium
levels were associated with mild or severe depression
defined as GDS scores 11 or higher.
Results
The GDS was administered to 1737 participants. Mean
age in the cohort is 74.3 years (SD= 5.2), with 53.1 %
being women and 61.1 % never attended school. Mean
BMI was 22.3 (SD= 3.8). In Table 1, we present mean
GDS scores by participants’ characteristics. Age, gender,
schooling, marital status, living arrangement, BMI, alco-
hol, smoking, histories of stroke, heart attack, head in-
jury, fractures and selenium levels were significantly
associated with GDS scores in each separate univariate
analysis. In Table 2, we present results of ANCOVA
models including significant factors associated with GDS
scores. Older age, living alone, lower BMI, history of
Table 1 Mean GDS scores by participants’ characteristics
(Continued)
No 1690 8.21 5.83
History of heart attack
Yes 52 12.00 6.42 >0.0001
No 1685 8.15 5.81
History of head injury
Yes 66 11.42 6.44 <0.0001
No 1671 8.14 5.81
History of fracture
Yes 30 12.47 6.00 <0.0001
No 1707 8.19 5.83
APOE e4 carriers
Yes 291 8.51 5.69 0.4360
No 1446 8.22 5.90
Selenium tertiles, μg/g 0.0132
Low (<0.32) 561 8.83 5.64
Medium [0.32, 0.47) 582 8.16 5.79
High (≥ 0.47) 594 7.83 6.10
Quartile groups defined by
composite cognitive score
<0.0001
Q4 (75 % to 100 %) 434 5.5 4.8
Q3 (50 % to 75 %) 434 7.7 5.7
Q2 (25 % to 50 %) 435 9.1 5.7
Q1 (0 to 25 %) 434 10.7 5.9
* Comparing those married to widowed, excluding those in the “other” group.
^ Blood pressure measure≥ 140/90 or self-reported history of hypertension.
#: 13 subjects had missing information on living arrangement and 2 subjects
had missing information on the history of stroke.
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ciated with higher GDS scores, while having attended
school and ever drinking alcohol were associated withTable 2 Results of analysis of covariance (ANCOVA) models b
measured by GDS score adjusting for other factors (n = 1735)
Without Cognitive Sco
Variable Estimate Std Err
Age, years 0.10 0.03
Attended school vs no school −1.40 0.29
Live alone 1.37 0.35
Ever drink alcohol −0.97 0.29
Body mass index −0.12 0.04
History of stroke 1.96 0.86
History of heart attack 3.31 0.80
History of head injury 2.74 0.72
History of fracture 3.00 1.05
Selenium, μg/g −1.66 0.77
Composite cognitive z-score
a Two subjects had missing information on history of stroke.lower GDS scores. In this model, higher selenium level
was associated with lower GDS scores while adjusting
for all other significant factors in the model. In a subse-
quent model using selenium tertile group instead of con-
tinuous selenium levels, we also found the lowest
selenium group had significant higher GDS score than
those in the highest selenium group (p = 0.0063) while
the medium selenium group is not significantly different
from the high selenium group (p = 0.2143) (Table 3).
In a second ANCOVA model in Table 2, we included
the composite cognitive z-score in the model to deter-
mine whether selenium’s association with GDS score is
independent of cognitive function. In this model, higher
cognitive scores were significantly associated with lower
GDS scores. However, selenium level was no longer sig-
nificantly associated with GDS scores indicating that
there is little direct effect from selenium on GDS scores.
In addition, selenium was significantly associated with
the composite cognitive z-score (p = 0.0011) in a separ-
ate ANCOVA model with the composite cognitive z-
score as dependent variable adjusting for the same
variables as in model 2.
In Figure 1, mean GDS scores in each selenium tertile
group were presented by quartile cognitive group. Lower
GDS scores were seen in the higher cognitive group while
mean GDS scores no longer show differences across sel-
enium tertile groups. Results obtained using non-
parametric ANCOVA models yielded similar results with
significant selenium and GDS association in the model
without cognitive score (β=−0.36, p = 0.0059) and non-
significance selenium and GDS association in the model
adjusting for cognitive score (β=−0.23, p = 0.0674).
Out of the 1737 individuals with GDS scores, 535
(30.8 %) met the criteria for depression (GDS ≥ 11).
Mean selenium levels were 0.39 μg/g (SD= 0.18) in theetween selenium levels and depressive symptoms
a
re With Cognitive Score
p-value Estimate Std Err p-value
0.0002 −0.00 0.03 0.8688
<0.0001 −0.41 0.29 0.1681
0.0001 1.53 0.34 <0.0001
0.0009 −0.74 0.28 0.0093
0.0012 −0.05 0.04 0.1470
0.0223 1.62 0.83 0.0500
<0.0001 3.55 0.77 <0.0001
0.0001 2.49 0.69 0.0003
0.0042 2.36 1.01 0.0190
0.0321 −0.93 0.75 0.2143
−0.38 0.20 <0.0001
Table 3 Results of analysis of covariance (ANCOVA) models between selenium tertile groups and depressive symptoms
measured by GDS score adjusting for other factors (n = 1735)a
Without Cognitive Score With Cognitive Score
Variable Estimate Std Err p-value Estimate Std Err p-value
Age, years 0.10 0.03 0.0002 0.01 0.03 0.6132
Attended school vs no school −1.39 0.29 <0.0001 −0.49 0.29 0.0932
Live alone 1.35 0.36 0.0002 1.47 0.34 <0.0001
Ever drink alcohol −1.03 0.29 0.0005 −0.74 0.29 0.0095
Body mass index −0.12 0.04 0.0016 −0.05 0.04 0.1311
History of stroke 1.98 0.86 0.0209 1.73 0.83 0.0364
History of heart attack 3.34 0.80 <0.0001 3.59 0.78 <0.0001
History of head injury 2.67 0.72 0.0002 2.43 0.69 0.0005
History of fracture 2.92 1.05 0.0054 2.64 1.01 0.0091
Selenium tertile group, μg/g
<0.32 0.96 0.35 0.0063 0.58 0.34 0.0876
[0.32, 0.47) 0.42 0.34 0.2143 0.29 0.32 0.3712
≥ 0.47 reference – – reference – –
Cognitive score quartile groups
Q4 (75 % to 100 %) −4.61 0.42 <0.0001
Q3 (50 % to 75 %) −2.64 0.39 <0.0001
Q2 (25 % to 50 %) −1.43 0.38 0.0001
Q1 (0 to 25 %) reference – –
a Two subjects had missing information on history of stroke.
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depressed subjects (p = 0.0006). Higher levels of selen-
ium were significantly associated with lower probability
of depression (OR= 0.40, p = 0.0047) in the logistic modelFigure 1 Mean GDS scores by selenium tertiles and cognitive
quartile groups.without adjusting for cognitive function. The association
between selenium levels and the probability of depression
remained significant (OR= 0.50, p = 0.0331) after adjust-
ing for cognitive function.
Discussions
In this rural elderly Chinese cohort with an extensive
range of selenium distribution, we found that lower sel-
enium levels were significantly associated with higher de-
pressive symptoms adjusting for demographic and
medical conditions. However, when cognitive function
was included as an independent variable in the model,
the relationship between selenium and depressive symp-
toms was no longer significant, suggesting that selenium’s
association with depressive symptoms is explained in part
by its association with cognitive function.
Several previous publications including observational
studies as well as clinical trials had examined the associ-
ation between selenium levels and depression in various
populations. Two studies observed that low selenium diet
was associated with worsening mood [2,3]. In addition,
there were studies showing that selenium supplementa-
tion or high dietary selenium was associated with
improved mood with the most significant effect seen in
participants with low dietary selenium [1,3,26]. However,
a recent randomized trial of selenium supplementation
found that a 6-month selenium supplementation had no
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pants age 60 to 74 from the United Kingdom [5]. The dif-
ferences in study findings between the recent trial and
previous results may be explained by differences in diet-
ary selenium levels of study participants. The UK trial
consisted of participants whose baseline selenium status
was higher than the UK national average [5]. It is known
that the brain has a unique feature in storing selenium
and it also receives priority supply of selenium in times
of deprivation [27]. Animal studies have shown that after
generations of selenium deficiency when selenium con-
centrations in liver, skeletal muscle and blood dropped to
below 1 % of normal level, the brain still retained 60 % of
selenium as in normal controls.[7] In addition, studies
have shown that plasma GP-x activity plateaus after suf-
ficient selenium supply indicating that selenium supple-
mentation in high selenium individuals may not provide
additional benefit [28]. It is perhaps not surprising that
the UK trial found no selenium effect as most of the par-
ticipants would already have adequate selenium supply
at baseline and additional supplementation was not able
to increase mood measures. However, results of the UK
trial still left open the question of whether low selenium
is associated with depression in those with low dietary
selenium levels at baseline.
The review of current literature suggests that long-
term exposure to low selenium may be needed to impact
brain function. The brain’s unique selenium metabolism
may also make it more difficult to show the effect of
short-term selenium exposure on brain function than on
other organs.
The rural Chinese population offers an opportunity to
investigate the association of long-term selenium expos-
ure and depression by identifying populations where sub-
stantial numbers are exposed to low selenium diet for an
extended length of time and comparing their depressive
symptoms to those with normal selenium levels. The
overwhelming majority of our study participants were
life-long residents of the same towns where they were
interviewed and very few take dietary supplements.
Hence the ascertained selenium levels can be inferred as
life-long exposure to selenium without the influence of
supplements. In this stable cohort, we found a significant
association between lower selenium levels and increased
depressive symptoms which is consistent with previous
reports in participants with low dietary selenium intake.
The mechanism underlying an association between sel-
enium and depression is not yet clear, although published
results point to the fact that selenium is important to
brain functions. In animal models, selenium deficiency
was shown to alter neurotransmitter turnover rate [29]
and sodium selenite protected against dopamine loss
[30]. In addition, the enzyme closely related to selenium
activity (GP-x) protected against neuron loss [31], celldeath [32], and decreased free radical generation or amyl-
oid beta peptide [33]. In human studies, selenium supple-
mentation was shown to reduce intractable epileptic
seizures [34,35]. A recent cross-sectional study reported
that whole blood GPX activity was significantly lower in
depressed patients than in normal controls [36]. More re-
search is needed to elucidate the biological mechanism
for selenium’s function in the brain.
To our knowledge, no previous studies on selenium
and depression have examined the role of cognitive func-
tion. Numerous studies have reported the co-existence of
cognitive impairment and depression [37], although the
underlying mechanism for such an association is not yet
established. Some suggest that depressive symptoms are
early manifestation of the dementia disorder [38], while
others believe that depression represents an independent
risk factor for cognitive decline [25]. We have previously
reported a significant relationship between selenium level
and cognitive function in the same cohort using data col-
lected from baseline [8]. The non-significant association
between selenium and depressive symptoms after adjust-
ing for cognitive function suggests that cognitive func-
tion plays an important role in the relationship between
selenium and depression.
Our study has a number of strengths. Selenium levels
were measured in nail samples reflecting stable long-
term exposure. The study included participants from
sites with extensive range of selenium exposure. In
addition, the majority of our study participants were life-
long residents of the same towns where they were inter-
viewed and the participants were known to have not
taken dietary supplements. Hence the ascertained selen-
ium levels can be inferred as life-long exposure to selen-
ium without the influence of supplements. A number of
cognitive instruments were used so that a reliable com-
posite measure of cognitive function can be derived.
There are also important limitations in this study. Our
results were based on cross-sectional analyses in the
sense that cognitive function and depressive symptoms
were measured at the same time. Longitudinal follow-up
of this cohort would be necessary to examine the casual
direction of the association between cognitive function
and depressive symptoms. A second limitation is that we
relied on the GDS to assess depressive symptoms rather
than clinical diagnosis of specific depressive disorders,
an approach adopted by many large epidemiological
studies [25,38]. Further limitations include the exclusion
of potentially important risk factors for depression such
as disability or social support.
Conclusions
In summary, we found that selenium level was inversely
related to depressive symptoms in models without adjust-
ing for cognition in this rural elderly Chinese cohort.
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the association between selenium and cognitive function.
Longitudinal follow-up of this cohort will be able to fur-
ther examine the complex relationship between selenium,
cognitive function and depressive symptoms.
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